- Home
- SGRP vs TENX Comparison
SGRP vs TENX Comparison
Compare SGRP & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- TENX
- Stock Information
- Founded
- SGRP 1967
- TENX 1967
- Country
- SGRP United States
- TENX United States
- Employees
- SGRP N/A
- TENX N/A
- Industry
- SGRP Business Services
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- SGRP Consumer Discretionary
- TENX Health Care
- Exchange
- SGRP Nasdaq
- TENX Nasdaq
- Market Cap
- SGRP 24.5M
- TENX 21.6M
- IPO Year
- SGRP 1996
- TENX N/A
- Fundamental
- Price
- SGRP $1.15
- TENX $6.05
- Analyst Decision
- SGRP
- TENX Strong Buy
- Analyst Count
- SGRP 0
- TENX 3
- Target Price
- SGRP N/A
- TENX $16.00
- AVG Volume (30 Days)
- SGRP 103.9K
- TENX 24.4K
- Earning Date
- SGRP 07-17-2025
- TENX 08-12-2025
- Dividend Yield
- SGRP N/A
- TENX N/A
- EPS Growth
- SGRP N/A
- TENX N/A
- EPS
- SGRP N/A
- TENX N/A
- Revenue
- SGRP $148,274,000.00
- TENX N/A
- Revenue This Year
- SGRP N/A
- TENX N/A
- Revenue Next Year
- SGRP N/A
- TENX N/A
- P/E Ratio
- SGRP N/A
- TENX N/A
- Revenue Growth
- SGRP N/A
- TENX N/A
- 52 Week Low
- SGRP $0.91
- TENX $2.80
- 52 Week High
- SGRP $2.48
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- SGRP 61.68
- TENX 57.60
- Support Level
- SGRP $1.10
- TENX $5.77
- Resistance Level
- SGRP $1.25
- TENX $6.19
- Average True Range (ATR)
- SGRP 0.06
- TENX 0.24
- MACD
- SGRP 0.02
- TENX 0.03
- Stochastic Oscillator
- SGRP 70.56
- TENX 72.33
About SGRP SPAR Group Inc.
SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.